Literature DB >> 18503097

CRBP-I in the renal tubulointerstitial compartment of healthy rats and rats with renal fibrosis.

Katrien Van Beneden1, Leo A van Grunsven, Caroline Geers, Marina Pauwels, Alexis Desmoulière, Dierik Verbeelen, Albert Geerts, Christiane Van den Branden.   

Abstract

BACKGROUND: Cellular retinol-binding protein I (CRBP-I), a member of the intracellular lipid-binding protein (iLBP) superfamily, is a specific marker of quiescent stellate cells in the healthy human liver. In the diseased fibrotic/cirrhotic liver, portal and septal myofibroblasts acquire CRBP-I expression, while activated hepatic stellate cells maintain their CRBP-I expression. Here, we investigate the distribution of CRBP-I in the renal cortex of healthy rats and rats with renal fibrosis.
METHODS: Kidneys of healthy and adriamycin-treated rats were studied by immunohistochemistry, using antibodies against CRBP-I, desmin, vimentin and alpha-smooth muscle actin (alpha-SMA). Double stainings were done with immunofluorescence. Western blotting was performed to semi-quantify the expression levels of vimentin, desmin, alpha-SMA and CRBP-I.
RESULTS: In the normal rat kidney, the convoluted proximal tubular epithelial cells express CRBP-I; no expression is found in the interstitium, nor in the glomeruli. In the adriamycin-induced fibrotic rat kidney, CRBP-I expression diminishes in the convoluted proximal tubular epithelial cells, whereas peritubular myofibroblasts in the interstitium acquire CRBP-I expression.
CONCLUSIONS: In the tubulointerstitial compartment of the adriamycin-induced fibrotic rat kidney, CRBP-I is expressed in a different pattern than in the healthy rat kidney. As the convoluted proximal tubular epithelial cells dedifferentiate during fibrosis, CRBP-I expression decreases. Furthermore, de novo expression of CRBP-I is found in activated myofibroblast-like cells in the interstitium of adriamycin-treated rats. CRBP-I is therefore a useful marker to identify a subpopulation of activated/ myodifferentiated fibroblasts in the rat kidney.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18503097     DOI: 10.1093/ndt/gfn290

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  Valproic acid attenuates proteinuria and kidney injury.

Authors:  Katrien Van Beneden; Caroline Geers; Marina Pauwels; Inge Mannaerts; Dierik Verbeelen; Leo A van Grunsven; Christiane Van den Branden
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

2.  Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver.

Authors:  Julien Villeneuve; Fanny Pelluard-Nehme; Chantal Combe; Dominique Carles; Christine Chaponnier; Jean Ripoche; Charles Balabaud; Paulette Bioulac-Sage; Sébastien Lepreux
Journal:  Comp Hepatol       Date:  2009-07-14

3.  HDAC inhibitors in experimental liver and kidney fibrosis.

Authors:  Katrien Van Beneden; Inge Mannaerts; Marina Pauwels; Christiane Van den Branden; Leo A van Grunsven
Journal:  Fibrogenesis Tissue Repair       Date:  2013-01-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.